MetaCap

iShares U.S. Pharmaceutical ETF (IHE)

NYSEARCA: IHEiSharesHealthETFUSD

100.09+1.23 (+1.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

IHE chart

Full chart

Key facts

Holdings
10
Inception
May 1, 2006
Issuer
iShares
Index tracked
—
Category
Health
52-week range
72.94 – 108.66
Volume / Avg
342.36K / 249.56K
Beta
—
Previous close
98.86

IHE ETF today

The iShares U.S. Pharmaceutical ETF (IHE) is an exchange-traded fund from iShares in the Health category. It charges an expense ratio of 0.37%, or $37.00 per year on a $10,000 investment, and manages $1.63 billion in assets. Its largest holding is Eli Lilly and Co (LLY) at 23.51% of assets, and the top 10 positions make up 78.9% of the portfolio out of 10 holdings.

The fund's trailing dividend yield is 1.43%. IHE launched on May 1, 2006.

Summary generated from market data by MetaCap's automated system. Methodology

IHE top 10 holdings

IHE holdings by weight
#HoldingWeight
1LLYEli Lilly and Co23.51%
2JNJJohnson & Johnson22.64%
3PFEPfizer Inc4.69%
4VTRSViatris Inc4.55%
5MRKMerck & Co Inc4.50%
6BMYBristol-Myers Squibb Co4.43%
7RPRXRoyalty Pharma PLC Class A4.40%
8ZTSZoetis Inc Class A4.35%
9JAZZJazz Pharmaceuticals PLC3.36%
10ELANElanco Animal Health Inc2.50%

Top 10 holdings: 78.9% of assets.

IHE performance

1 week

+0.70%

IHE price return, excluding dividends.

ETFs similar to IHE

IHE ETF FAQ

What is the IHE price today?

IHE last traded at $100.09 as of Oct 9, 4:00 PM EDT, up 1.24% on the day.

What is IHE's expense ratio?

IHE has an expense ratio of 0.37%, which works out to about $37.00 per year for every $10,000 invested.

What are IHE's top holdings?

IHE's largest holdings are Eli Lilly and Co (23.51%), Johnson & Johnson (22.64%), Pfizer Inc (4.69%), Viatris Inc (4.55%), Merck & Co Inc (4.50%). The top 10 make up 78.9% of the fund.

Does IHE pay a dividend?

Yes. IHE has a trailing dividend yield of 1.43%.

How big is IHE?

IHE has about $1.63 billion in assets under management spread across 10 holdings.

Explore